Chengdu Kanghong Pharmaceutical Group: Net profit is 369 million in 2025, a year-on-year increase of 292.21%

Sina Finance reported on March 30 that Morning Light Bio announced a operating income of 6.59 billion yuan in 2025, a decrease of 6.22% compared to the previous year. Net profit was 3.69 billion yuan, an increase of 292.21% year-on-year. The profit distribution plan approved by the board of directors is as follows: based on 4.83 billion shares, a cash dividend of 3 yuan per 10 shares will be distributed to all shareholders, no bonus shares will be issued, and no additional shares will be given to all shareholders from the capital reserve fund per 10 shares.